Home » Newsletters » BioWorld Asia

BioWorld Asia

May 26, 1999

View Archived Issues

TAB, Proteus Will Merge To Form #63M Company

Protein Discovery Could Lead To Oxygen-Sensing Answers

Evotec, Qiagen Form Venture For Nucleic Acid Systems

Chiroscience Finds Bone Gene With Osteoporosis Implications

BresaGens IPO Will Help Fund Work In Stem Cells

Phase II Trials Under Way For Xenovas XR9576 Drug

XTLs Trimera HBV Mouse Model Demonstrates Antiviral Efficacy

Israel Seeks European Partners

Oxford Biomedica Partners With Korean Gene Therapy Company

Biotech Salmon In The Pink

Celltech On Track To File U.S. NDA In Third Quarter

Alizyme Gets OK For Phase II On Renzapride

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...